A phase III trial of somavartan in adults with growth hormone deficiency

Trial Profile

A phase III trial of somavartan in adults with growth hormone deficiency

Planning
Phase of Trial: Phase III

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Somavaratan (Primary)
  • Indications Somatotropin deficiency
  • Focus Therapeutic Use
  • Acronyms VITAL
  • Most Recent Events

    • 08 Mar 2017 New trial record
    • 02 Mar 2017 This trial is expected to begin by the end of 2017, according to a Versartis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top